News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
266 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (27010)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (266)
2 (303)
3 (319)
4 (449)
5 (141)
6 (5)
7 (8)
8 (327)
9 (447)
10 (392)
11 (296)
12 (287)
13 (12)
14 (10)
15 (364)
16 (243)
17 (199)
18 (254)
19 (138)
20 (3)
21 (22)
22 (199)
23 (184)
24 (146)
25 (10)
26 (23)
27 (1)
28 (31)
29 (202)
30 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
New Precision Platform Could Be Cell Therapy Game-Changer
BlueSphere Bio aims to overcome challenges in the CAR T space with a precision approach to T cell therapy.
November 1, 2021
·
6 min read
·
Heather McKenzie
Deals
LianBio Banks $325 Million IPO to Bring New Drugs to Asian Markets
One year after snagging $310 million in a financing round, LianBio raised $325M in its initial public offering. Its stock begins selling today on Nasdaq under the ticker symbol “LIAN.”
November 1, 2021
·
2 min read
·
Alex Keown
BioMidwest
World Hits 5 Million COVID-19 Deaths While US Sees Reprieve
As the world marks a grim milestone of 5 million COVID-19 deaths, public health officials are keeping a close watch on a substrain of the Delta variant.
November 1, 2021
·
3 min read
·
Mark Terry
Drug Development
Teva’s Risperidone Injectable Wards Off Schizophrenia Relapse in Phase III
Researchers found that those who took either the once-a-month or once-every-two-month doses experienced longer periods before relapsing.
November 1, 2021
·
2 min read
·
Vanessa Doctor, RN
Business
Merck and Synthekine Strike $525 Million Cytokine Therapy Deal
Under the agreement, Merck can use Synthekine’s surrogate cytokine agonist platform to discover, develop, and sell new cytokine-based treatments for up to two cytokine targets.
November 1, 2021
·
2 min read
·
Vanessa Doctor, RN
Business
Inovio and AstraZeneca Terminate Six-Year-Old DNA Cancer Vaccine Program
Inovio shares are down about 2% in premarket trading after cancellation reports of a DNA cancer vaccine collab with AstraZeneca.
November 1, 2021
·
2 min read
·
Alex Keown
BioCapital
AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis
The acquisition of the medicines – which netted AstraZeneca $143 million in the geographies covered under the agreement – provides a significant boost to Covis’s respiratory portfolio.
November 1, 2021
·
2 min read
·
Heather McKenzie
Drug Development
Merck Delays Acceleron Deal Amidst Continuing Stakeholder Criticism
The decision came after Avoro Capital Advisors, which owns a 7% stake in Acceleron, posted its objections to the deal.
November 1, 2021
·
2 min read
·
Alex Keown
Deals
Acquisition Rumors Continue to Circulate Around Aurinia as GSK Denies Interest
GlaxoSmithKline denied reports that they were interested in acquiring Canada’s Aurinia Pharmaceuticals, although some reports claim they are preparing to bid.
November 1, 2021
·
3 min read
·
Mark Terry
Drug Development
Moderna COVID-19 Vaccine Unlikely to Be Authorized for Adolescents in 2021
The FDA informed Moderna that it would need more time to evaluate the company’s Emergency Use Authorization (EUA) submission for its COVID-19 vaccine for adolescents 12 to 17 years of age.
November 1, 2021
·
3 min read
·
Mark Terry
1 of 27
Next
